Cowen analyst Chris Shibutani downgraded Achaogen (NASDAQ: AKAO) from Outperform to Market Perform.The analyst comments "Even acknowledging share ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE